Results 301 to 310 of about 102,119 (362)

COVID‐19 pandemic impact on blood donations and discards from screening tests for transfusion‐transmitted infections in a Brazil Brazilian metropolitan area

Transfusion Medicine, EarlyView.
Abstract Background The COVID‐19 pandemic posed a worldwide challenge for blood services. We aimed to evaluate the impact of the COVID‐19 pandemic on blood donations and blood discards resulting from screening tests for transfused‐transmitted infections (TTIs) in a Brazilian metropolitan.
Laiane da Silva Santos, Sérgio Eduardo Soares Fernandes, Flávio Ferreira Pontes Amorim, Anna Luiza Oliveira Sant'Anna, Felipe Ferreira Pontes Amorim, Fábio Ferreira Amorim   +5 more
wiley   +1 more source

How do I interpret transfusion transmissible infectious disease testing in a low‐risk donor population?

Transfusion, EarlyView.
Abstract Background Blood donors represent a unique population. Pre‐donation screening questions, donor self‐deferral, and temporary deferral and re‐testing of repeat reactive donors result in lower prevalence of infectious disease compared to the general population.
Carmen L. Charlton, Mark Bigham, Sheila F. O'Brien, Steven J. Drews   +3 more
wiley   +1 more source

Quantitative bead-based multiplex assay for simultaneous determination of IgG concentrations of pertussis toxin, filamentous hemagglutinin, pertactin, diphtheria, tetanus, Haemophilus influenzae b, and hepatitis B in human serum samples. [PDF]

Front Immunol
Rathod V, Katke S, Patil S, Bhandare S, Kadam L, Gautam M, Gumma P, Kumar KM, Hassall L, Asokanathan C, Douglas-Bardsley A, Markey K, Gupta S, Rao H, Parekh S, Pujari P, Sharma H, Shaligram U, Gairola S.   +18 more
europepmc   +1 more source

Perceptions of deferred blood donors regarding false‐positive screening results for infectious diseases and European blood establishment strategies

Vox Sanguinis, EarlyView.
Abstract Background and Objectives This study explores the perceptions of deferred blood donors in the Netherlands regarding the information provided upon receiving false‐positive screening (FPS) deferral letters for infectious diseases. To ensure blood supply safety, rigorous screening for infectious agents is implemented by blood establishments ...
Jenny Erica Beckman, Niubel Díaz Padilla, Afke van der Woud, Peter van den Burg, Vĕra Novotny   +4 more
wiley   +1 more source

Analysis of HBV infection characteristics and OBI prevalence in pregnant women: a focus on HBcAb + alone or in combination with HBeAb + subgroups in Northwest China. [PDF]

BMC Infect Dis
Xie Y, Kang R, Cheng X, Li D, Wang Q, Li J, Guo X, Gao W, He X, Jiang L, Meng G.   +10 more
europepmc   +1 more source

Xenotransplantation: principles and practice [PDF]

, 1996
Fung, JJ, Starzl, TE, Todo, S, Valdivia, L   +3 more
core  

Circulating Hepatitis B Virus (HBV) RNA and Conventional Markers in Treatment-Naive Persons With HBV in Senegal. [PDF]

J Infect Dis
Begré L, Akotia MK, Wembulua BS, Pandi M, Ndiaye O, Tine J, Bittel P, Niederhauser C, Stolz M, Rauch A, Ngom NF, Ramírez Mena A, Wandeler G, Seydi M, Senegalese Hepatitis B Cohort Study (SEN-B).   +14 more
europepmc   +1 more source

HBx promotes podocyte-macrophage transdifferentiation by mediating NLRP3 expression in hepatitis B virus-associated glomerulonephritis. [PDF]

Virol J
He Z, Zhu Y, Niu Y, Guan H, Yang Y.
europepmc   +1 more source

Hepatitis B virus and hepatitis D virus co-infection complicated by autoimmune hepatitis: Two case reports. [PDF]

World J Clin Cases
Dou J, Zhao XY, Wang ZG, Ning ZH, Wang XZ, Guo F.   +5 more
europepmc   +1 more source

In Vitro Anti-Hepatitis B Virus Activity of Hydroxytyrosol from <i>Lindernia ruellioides</i>. [PDF]

Molecules
Zhao TS, Li KZ, Su HL, Liang B, Liang CQ, Gao JT, Zhou XL.   +6 more
europepmc   +1 more source